Zen Technologies

ZENTEC (₹1,712.00) exhibits a mixed technical posture as of November 6, 2026. On the daily horizon, price remains above all key moving averages and the Supertrend, signaling a developing bullish trend (ADX 22.83). However, momentum is fragmented: a high-participation downward anomaly on Nov 6 (volume ratio 2.93) followed by an active Doji pattern suggests indecision rather than clear directional conviction. The stock trades in the upper-middle of its 20-day range (+72.7%) but sits near the middle of its 252-day range (+59.6%).

Conflicts arise across timeframes. While the weekly structure is bullish with price above the Supertrend, the monthly trend is bearish (price below Supertrend, weak ADX 16.88), indicating longer-term pressure. Volatility is elevated (annualized +46.8%, ATR 4.3%), and the stock remains significantly off its maximum drawdown (-61.7%). Immediate resistance lies at ₹1,719.21 (0.42% above), while support is found at ₹1,701.43 (0.62% below). A break below ₹1,701.43 would challenge the daily bullish alignment, whereas a sustained move above ₹1,719.21 could confirm renewed upward participation.

Zen Technologies reported record financial results for Q2 FY27, with consolidated revenue from operations nearly doubling to ₹345.13 crore and net profit rising to ₹90 crore (₹89.54 crore). The company secured new orders worth ₹481.81 crore during the quarter, expanding its total consolidated order book to ₹1,375.70 crore as of September 30, 2026. Chairman Ashok Atluri attributed this performance to core technology ownership enabling faster adaptation under Fast Track Procurement routes. Following these results, Zen Technologies shares surged 8.32%. Choice Institutional Equities upgraded the stock to a 'Buy' rating with a target price of ₹2,150, citing strong order inflows and indigenous capabilities, while revising FY27 and FY28 estimates upward. Broader market analysis also identifies Zen Technologies among key private-sector defence players benefiting from India's localisation push, though it notes premium valuations relative to public sector undertakings.

Zen Technologies reported record quarterly revenue of ₹345.1 crores for Q2 and H1 FY2027, reflecting a 98.8% year-on-year increase, alongside an operational EBITDA margin of 38.2%. The consolidated order book stood at ₹1,375.7 crores as of September 30, 2026. Management confirmed the company remains debt-free with ₹968 crores in cash; however, working capital cycles extended to 379 days due to receivables from back-ended revenue and supplier advances for execution. Future revenue guidance targets ₹4,000 crores over two financial years, contingent on government procurement processes, specifically Fast Track Procurement (FTP) for counter-drone systems expected in Q4 or by March 31, 2027. On November 5, 2026, the company transferred 6,375 equity shares to employees under ESOP-2021, with no change to the total issued share capital of 9,02,90,356 shares. As of November 6, 2026, the stock traded at ₹1,712.00.

Zen Technologies reported record Q2 FY2027 revenue of ₹345.13 crore, up 98.8% year-on-year, with an operational EBITDA margin of 38.2%. The consolidated order book stands at ₹1,375.70 crore as of September 30, 2026. Management highlighted a debt-free status with ₹968 crore in cash but noted working capital cycles increased to 379 days due to receivables and supplier advances. Future revenue guidance targets ₹4,000 crore over two years, contingent on government procurement, specifically Fast Track Procurement (FTP) for counter-drone systems expected by March 31, 2027.

On the corporate action front, the Board approved the acquisition of 51.98% stake in Cogknit Semantics Private Limited for ₹135.15 crore, pending customary conditions. Additionally, the voluntary strike-off of wholly-owned subsidiary Zen Medical Technologies Private Limited was approved. A fire incident at subsidiary Unistring Tech Solutions Private Limited resulted in a preliminary estimated loss of approximately ₹4.00 crore. Regarding capital structure, the company exercised 6,375 ESOP options on November 5, 2026, with no change in paid-up share capital. Monitoring agency reports confirm that proceeds from the Qualified Institutional Placement (QIP) raised at ₹97,950.77 lakhs are being utilized per disclosures, with ₹24,166.04 lakhs currently invested in fixed deposits.

Zen Technologies demonstrated a sharp operational recovery in Q2 FY2026-27, with revenue jumping 99% year-on-year to ₹345 crore and net profit tripling to ₹102 crore. This follows a significant contraction in the prior year (Sep 2025), where sales fell 28%. The current quarter's earnings quality is strong, evidenced by CFO/EBITDA reaching 136%, indicating that operating profits are converting efficiently into cash. However, this growth has coincided with a substantial expansion in working capital requirements; inventory days surged from 118 to 415, and trade receivables increased to ₹479 crore as of Sep 2026. Consequently, cash reserves declined from ₹370 crore to ₹260 crore despite robust operating inflows, suggesting that cash is being deployed into inventory buildup and receivables rather than retained. While borrowings remain low at ₹29 crore, the shift in cash management dynamics warrants close monitoring.

Zen Technologies presents a constructive case anchored by exceptional operational momentum in Q2 FY27, despite broader market volatility. The company reported its highest-ever consolidated quarterly revenue of ₹345.13 crore, nearly doubling year-on-year, alongside a 103.9% surge in operational EBITDA. This execution strength is reinforced by robust order inflows of ₹481.81 crore during the quarter, which expanded the total consolidated order book to ₹1,375.70 crore as of September 30, 2026. Chairman Ashok Atluri attributes this performance to core technology ownership enabling faster product adaptation and timely delivery under Fast Track Procurement channels. Additionally, Choice Institutional Equities has upgraded the stock to 'Buy' with a target price of ₹2,150, citing these record revenues and strong order visibility. While the stock faces near-term technical headwinds, including a current drawdown of -32.6% and bearish monthly trend signals, the fundamental backdrop of accelerating revenue growth and an expanding order pipeline provides a clear conditional upside case driven by indigenous defense capabilities.

Zen Technologies faces significant valuation and volatility risks despite strong operational execution. The stock trades at a premium to public sector peers, with analysts noting that mid-cap defence players often command higher valuations due to superior margins but face corresponding risks in order execution and procurement timing. Technically, the share price has experienced a severe correction, currently sitting 32.6% below its recent peak, with a maximum historical drawdown of -61.7%. Annualized volatility is elevated at 46.8%, indicating substantial price instability. While the monthly technical trend is bearish, the stock remains sensitive to near-term resistance levels just above the current ₹1,712 price point, requiring sustained momentum to overcome immediate overhead supply.